Sexually Transmitted Disease RT-PCR Testing Panel
According to an IMARC group report, in 2022, the global sexually transmitted disease (STD) diagnostics market will be worth US$ 98.71 billion. Looking ahead, IMARC Group forecasts the market to reach US$ 135.94 billion by 2028, with a compound annual growth rate (CAGR) of 5.39% from 2023 to 2028.
With more than 20 million STDs reported in the US each year, it's time to take action and stay informed about your health. That's why we offer a comprehensive STD testing panel that shows the most common STD tests all in one place.
Your Safety Matters: Get Tested for STIs with Nobelza's RT-PCR Technology!
Knowing your status can help reduce the spread of STDs and help you make empowered decisions about your health. Get tested today with our STD testing panel for piece of mind! Nobelza lab on chip platform can be customised to test sexually transmitted disease (STD). The test looks for nucleic acid in the blood that could indicate the presence of an STD. HIV, syphilis, gonorrhoea, chlamydia, trichomoniasis, and herpes are all common STDs that can be tested for on Nobelza platform. Other infections, such as hepatitis B and C, and parasites, can also be detected by modifying the testing panel. The STD testing panel is a simple and effective method of detecting STDs in a single reaction in a cost and time effective way.